Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
By this week, it was down to fewer than 100
Your provider may also need time to review any medications you currently take for potential interactions
According to the SURPASS-5 clinical trial, after 40 weeks on varying doses of tirzepatide, participants experienced an average reduction in A1C of 2% with the 5 mg dose, 2.4% with the 10 mg dose, and 2.34% with the 15 mg dose
We did not restrict our study to patients who were highly adherent with their medication either, which may better reflect the utility of these medications in every day clinical practice. White and colleagues collected electronic health records and health insurance claims data from 2,405 adults aged 18 years and older receiving care at a large health care system in western Pennsylvania who were dispensed a GLP-1 receptor agonist from 2011 to 2018 (mean age, 48 years
US$ 24.39
US$ 24.77
US$ 25.82
US$ 23.31
